Galimedix Therapeutics, Inc.
Galimedix Therapeutics is a Phase 2 clinical-stage company developing novel oral and topical neuroprotective therapies to transform the treatment of major neurodegenerative diseases of the eye and brain. Their groundbreaking small molecules target amyloid beta to address diseases like dry AMD, glaucoma, and Alzheimer’s. The company's approach focuses on blocking the formation of toxic oligomers and protofibrils of amyloid beta without impacting normal neuronal function. Galimedix's pipeline includes product candidates with potential to slow or stop neurodegeneration and restore lost neuronal function, with a lead program, topical GAL-101, entering Phase 2 proof-of-concept studies in dry AMD.
Galimedix Therapeutics, Inc.
Galimedix Therapeutics is a Phase 2 clinical-stage company developing novel oral and topical neuroprotective therapies to transform the treatment of major neurodegenerative diseases of the eye and brain. Their groundbreaking small molecules target amyloid beta to address diseases like dry AMD, glaucoma, and Alzheimer’s. The company's approach focuses on blocking the formation of toxic oligomers and protofibrils of amyloid beta without impacting normal neuronal function. Galimedix's pipeline includes product candidates with potential to slow or stop neurodegeneration and restore lost neuronal function, with a lead program, topical GAL-101, entering Phase 2 proof-of-concept studies in dry AMD.
galimedix.com
3704 Calvend Ln Kensington, Maryland 20895, US
Details
Year founded
2018
Revenue
1M-5M
Employees
1-10
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- GAL-101
- GAL-201
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Small molecule development equipment for drug manufacturing
- Oral and topical drug administration equipment
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that galimedix therapeutics is not ramping up production.
Target industries
Employees working in Galimedix Therapeutics, Inc.
Employees working in Galimedix Therapeutics, Inc.
Locations (1)
Galimedix Therapeutics, Inc.
3704 Calvend Ln Kensington, Maryland 20895, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Galimedix Therapeutics, Inc. offer?
Galimedix Therapeutics, Inc. offers a range of services and capabilities, including GAL-101.
What kind of equipment does Galimedix Therapeutics, Inc. use?
Galimedix Therapeutics, Inc. uses a variety of equipment, including Small molecule development equipment for drug manufacturing.
What are the target industries of Galimedix Therapeutics, Inc.?
Galimedix Therapeutics, Inc. serves several industries, including the medical industry.
How many locations does Galimedix Therapeutics, Inc. operate?
Galimedix Therapeutics, Inc. operates from a single location at 3704 calvend lane, kensington, maryland 20895, united states.
Where are the headquarters of Galimedix Therapeutics, Inc.?
The headquarters of Galimedix Therapeutics, Inc. are located in 3704 calvend lane, kensington, maryland 20895, united states.
What is the NAICS code for Galimedix Therapeutics, Inc.?
The NAICS code for Galimedix Therapeutics, Inc. is 3254.
How many employees does Galimedix Therapeutics, Inc. have?
Galimedix Therapeutics, Inc. has 7 employees.
What is the official website of Galimedix Therapeutics, Inc.?
The official website of Galimedix Therapeutics, Inc. is https://www.galimedix.com/.
When was Galimedix Therapeutics, Inc. founded?
Galimedix Therapeutics, Inc. was founded in 2018.